N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential universal biomarker for several malignant tumors, including lung cancer, breast cancer, and head and neck cancer. Insufficient activity of N-Acetylgalactosamine-6-Sulfatase can lead to mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. This enzyme is utilized in research related to MPS IVA and cancer.
* VAT and and shipping costs not included. Errors and price changes excepted